Lausanne-based Reshape Systems SA, a spin-off from the European Center for Nuclear Research (CERN), has announced the closing of an oversubscribed €856k pre-Seed funding round to address the most pressing challenges in risk analysis.
The round was led by Backbone Ventures joined by Heartfelt, GF BRYCK Ventures (by Gründerfonds Ruhr and BRYCK), Kyle Kosic (xAI Co-founder, now at OpenAI) and N&V Capital.
“This investment represents a pivotal point in Reshape Systems’ growth, allowing us to expand our team and scale up the development and adoption of our risk analysis platform,” said Dr Andrea Apollonio, Co-founder and CEO of Reshape Systems, who holds a PhD specialising in risk analysis methods for particle accelerators and has held various leadership roles at CERN over the last decade.
Founded in 2024, Reshape Systems specialises in advanced AI-powered solutions for the risk analysis of complex industrial systems. Founded as a spin-off of CERN, Reshape Systems combines deep research roots with industry expertise to serve critical sectors with “state-of-the-art, transparent, and explainable AI“.
The way it works is that users provide project documentation – including functional or technical specifications, technical drawings, or any other relevant information – and gain access to a risk-analysis co-pilot: a platform designed to support project management across all stages of the life cycle, from concept to operations.
The platform automates widely used industry risk analysis methods and ensures compliance with applicable safety standards. It delivers automated risk analysis with direct integration into existing company workflows and tools, offers an intuitive user interface for navigating complex projects with thousands of risks, enables one-click updates when project information changes, and generates standardised risk analysis reports.
“In high-stakes industrial environments – such as automotive, aerospace, nuclear, and manufacturing – trust and transparency are essential. We are committed to providing explainable, user-supervised AI solutions that give decision-makers the confidence to safely innovate, reduce risk, and ensure operational continuity,” said Dr Thomas Cartier-Michaud (Co-founder and CTO), a PhD in plasma physics and AI expert who brings R&D experience from both major research institutions and the HealthTech startup sector.
Today, companies are under pressure to deliver increasingly complex products in shorter timeframes, while navigating supply chain disruptions and high staff turnover, factors that Reshape Systems says intensify the challenges related to risk analysis and certification processes.
With their expertise in designing safety-critical systems and a foundation rooted in research excellence at CERN, Reshape Systems integrates the latest AI technologies in their aim to meet the evolving demands of modern industry.
Reshape Systems’ platform reportedly helps companies reduce engineering costs, improve knowledge management, and accelerate time-to-market for new products, while maintaining the highest safety and reliability standards.
